Therapeutics

EndoLipiD Therapeutics

sergiserrano, 14 March, 2023, 0

EndoLipiD Therapeutics EDL6D a new NASH therapy Therapeutics Prototyping, preclinical Spain Status Approved IP Type PCT Time 14 years...

+

Amplio Pharma AB

sergiserrano, 7 February, 2023, 0

Amplio Pharma AB Methotrexate Forte - an innovation towards its clinical proof of concept Therapeutics Development, market readiness, clinical trial...

+

IDP Pharma

sergiserrano, 30 January, 2023, 0

IDP Pharma Transforming cancer treatment, forever Therapeutics Development, market readiness, clinical trial Spain 1.000.000€ Status Approved IP Type Patent Time...

+

Miramoon Pharma

Pablo Ferrón, 27 January, 2023, 0

Miramoon Pharma First in Class Drugs for Neurodegenerative and Rare Diseases Therapeutics Prototyping, preclinical España 700.000€ Status Approved IP Type...

+

PhosPrint P.C

sergiserrano, 17 January, 2023, 0

PhosPrint P.C PhosPrint P.C Therapeutics Prototyping, preclinical Greece 800.000€ Status Pending IP Type PCT Time - Countries Austria Belgium Denmark...

+

Prospera Biotech

Antonio Ferrer, 3 January, 2023, 0

Prospera Biotech Innovative neurodermatological solutions to improve quality of life of cancer patients treated with chemotherapy Biotech Sales, licensing phases...

+

DRYOX HEALTH

Montse Vallet Buisan, 2 August, 2022, 0

DRYOX HEALTH Start-up created in Barcelona led by a group multidisciplinary professionals with high expertise in the pharma industry Therapeutics...

+

DevsHealth

Alfons Nonell-Canals, 25 July, 2022, 0

DevsHealth We are a DeepTech company using AI, RWD and quantum computing to develop new anti-infectious treatments Therapeutics Development, market...

+

Oncostellae

Montse Vallet Buisan, 23 May, 2022, 0

Oncostellae Developing safer, GI-targeted treatments in IBD and Colorectal cancer Therapeutics Development, market readiness, clinical trial Spain 3.300.000€ Status Approved...

+

ENDOLIPID THERAPEUTICS

Albert Palomer, 4 October, 2021, 0

ENDOLIPID THERAPEUTICS NASH and Cellulite innovative therapies. Therapeutics Development, market readiness, clinical trial España 500.000€ Status Approved IP Type...